Tailor our services to meet your Japanese market entry needs
CMIC provides end-to-end solutions for market entry into Japan. Our 50+ experienced consultants will help you determine the best strategy in accordance with Japan-specific changing regulations and unique environment, working flexibly with your company’s plans for market entry. We provide options for entry at any stage in drug development before clinical trials have started abroad, after approval abroad or after commercializing in a different country. As a Pharmaceutical Value Creator, CMIC strives to provide value by spanning our services across the entire drug development value chain. Download our brochure on Japan Market Entry to learn more.
Inquiries about our services
Click below if you are interested in outsourcing your operations to us.
